PL219242A1 - - Google Patents

Info

Publication number
PL219242A1
PL219242A1 PL21924279A PL21924279A PL219242A1 PL 219242 A1 PL219242 A1 PL 219242A1 PL 21924279 A PL21924279 A PL 21924279A PL 21924279 A PL21924279 A PL 21924279A PL 219242 A1 PL219242 A1 PL 219242A1
Authority
PL
Poland
Application number
PL21924279A
Other versions
PL119712B1 (en
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of PL219242A1 publication Critical patent/PL219242A1/xx
Publication of PL119712B1 publication Critical patent/PL119712B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL1979219242A 1978-10-27 1979-10-26 Process for preparing 6-piperidin-2,4-diaminopyrimidine 3-oxideina PL119712B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU78EE2594A HU177601B (en) 1978-10-27 1978-10-27 New process for preparing 6-piperidino-2,4-diamino-pyrimidine-3-oxide

Publications (2)

Publication Number Publication Date
PL219242A1 true PL219242A1 (sv) 1980-06-16
PL119712B1 PL119712B1 (en) 1982-01-30

Family

ID=10995794

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1979219242A PL119712B1 (en) 1978-10-27 1979-10-26 Process for preparing 6-piperidin-2,4-diaminopyrimidine 3-oxideina

Country Status (14)

Country Link
JP (1) JPS5559172A (sv)
AT (1) AT373246B (sv)
CH (1) CH642365A5 (sv)
CS (1) CS213398B2 (sv)
DE (1) DE2943161A1 (sv)
DK (1) DK454579A (sv)
ES (1) ES485457A1 (sv)
FI (1) FI793307A (sv)
GB (1) GB2032434B (sv)
HU (1) HU177601B (sv)
PL (1) PL119712B1 (sv)
SE (1) SE432596B (sv)
SU (1) SU913942A3 (sv)
YU (1) YU262579A (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179344A (en) * 1981-07-15 1984-12-11 Jean-Claude Muller Process for the preparation of 6-¬3,6-dihydro-1(2h)- pyridyl| pyrimidine-3-oxides
CH649291A5 (de) * 1982-03-16 1985-05-15 Hoffmann La Roche Dicarbamate.
HU196061B (en) * 1986-07-10 1988-09-28 Richter Gedeon Vegyeszet Process for production of pirimidine-derivatives
HU196067B (en) * 1986-07-10 1988-09-28 Richter Gedeon Vegyeszet Process for production of 6-amin-1,2-dihydro-1-hydroxi-2-imino-4-piperidin-piramidin
FI864046A (fi) * 1986-10-07 1988-04-08 Farmos Oy Foerfarande foer framstaellning av en terapeutiskt aktiv foerening.
LU86958A1 (fr) * 1987-07-31 1989-03-08 Oreal Sels d'acide thiamorpholinone carboxylique et de derives de diamino-2,4 pyrimidine,leur utilisation en cosmetique et pharmacie
LU86960A1 (fr) * 1987-07-31 1989-03-08 Oreal Procede de preparation de piperidino-6 diamino-2,4 pyrimidine oxyde-3 et composes nouveaux
US4959475A (en) * 1989-01-04 1990-09-25 Lonza Ltd. Process for the production of 2,4-diamino-6-piperidinyl-pyrimidine-3-N-oxide

Also Published As

Publication number Publication date
HU177601B (en) 1981-11-28
CS213398B2 (en) 1982-04-09
DE2943161A1 (de) 1980-05-08
YU262579A (en) 1983-01-21
SU913942A3 (en) 1982-03-15
DK454579A (da) 1980-04-28
SE432596B (sv) 1984-04-09
FI793307A (fi) 1980-04-28
CH642365A5 (de) 1984-04-13
PL119712B1 (en) 1982-01-30
ATA689879A (de) 1983-05-15
GB2032434A (en) 1980-05-08
JPS5559172A (en) 1980-05-02
SE7908629L (sv) 1980-04-28
GB2032434B (en) 1982-11-17
ES485457A1 (es) 1980-10-01
AT373246B (de) 1983-12-27

Similar Documents

Publication Publication Date Title
FR2413974B1 (sv)
FR2416853B1 (sv)
FR2417008B3 (sv)
FR2415990B3 (sv)
FR2414726B1 (sv)
FR2416320B1 (sv)
FR2414892B1 (sv)
DK142494C (sv)
FR2417125B1 (sv)
FR2416528B1 (sv)
FR2414825B3 (sv)
BG26007A1 (sv)
BG25957A1 (sv)
CH619829GA3 (sv)
BG26774A1 (sv)
BG26120A1 (sv)
BG26022A1 (sv)
BG26017A1 (sv)
BG26015A1 (sv)
BG26014A1 (sv)
BG26013A1 (sv)
BG26012A1 (sv)
BG26009A1 (sv)
BG26008A1 (sv)
BG26967A1 (sv)